The 3 Most Undervalued Biotech Stocks to Buy in April 2024

With the market off to a rather wobbly start to the second quarter of 2024, investors may be looking for the most undervalued biotech stocks to buy in April that can offer more bang for one’s buck. For new investors seeking reasonable valuations and overlooked long-term growth drivers, the biotech scene is worth considering.With the rise of diabetes drugs, whose benefits may extend beyond losing weight (a recent study shed light on its ability to help treat Parkinson’s Disease potentially), the biotech indu ...